Protagenic Therapeutics is categorized under Biological Research in New York City, NY and active since 2010.
Protagenic Therapeutics was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Biological Research business, which does work in the B2B market, and is classified as a Biological Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Haro Hartounian at the company’s single location by writing to 149 5th Avenue Floor 5, New York City, New York NY 10010 or by phoning (212) 994-8202. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Protagenic Therapeutics |
| Contact Person: | Haro Hartounian |
| Address: | 149 5th Avenue Floor 5, New York City, New York 10010 |
| Phone Number: | (212) 994-8202 |
| Website Address: | protagenic.com |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Protagenic Therapeutics was started in 2010 to provide professional Biological Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Haro Hartounian for inquiries that concern Protagenic Therapeutics by calling the company number (212) 994-8202, as your correspondence is most welcome. Additionally, the physical location of the single location of Protagenic Therapeutics can be found at the coordinates 40.740314,-73.990275 as well as the street address 149 5th Avenue Floor 5 in New York City, New York 10010.
For its online presence, you may visit Protagenic Therapeutics’s website at protagenic.com and engage with its social media outlets through on Twitter and on Facebook.